The Spanish registry of adverse reactions to biological therapies (BIOBADASER) has found a higher incidence of infections in patients with rheumatoid arthritis (RA) who receive anti-TNF therapies (4). The gene discussed is TNF; the disease is rheumatoid arthritis.